GlassScriptPhysician profile
Najeeb M Thomas
NPI 1073538096
$439,739.22
in general payments reported to CMS, 2019-2025
23 companies · $59K in 2025
The $59K reported for 2025 was more than what 96% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $72K · 2021: $57K · 2022: $73K · 2023: $70K · 2024: $37K · 2025: $59K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $142K · Consulting Fee: $17K · Travel and Lodging: $6,156 · Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $141,819.54 |
| Consulting Fee | $17,425.00 |
| Travel and Lodging | $6,155.54 |
| Food and Beverage | $949.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $196,394.61 | 2019-2023 | Coalesce, Nuvasive, Excavation |
| The Institute of Musculoskeletal Science and Education | $82,224.59 | 2021-2025 | Spira |
| Globus Medical, INC. | $55,792.86 | 2022-2025 | Nts, Excelsius Gps, Coalesce |
| Zimmer Biomet Holdings, INC. | $55,715.64 | 2019-2021 | |
| Zimvie INC. | $17,458.39 | 2022-2023 | |
| Si-Bone, INC. | $13,214.34 | 2019-2025 | |
| Curiteva, INC. | $12,150.11 | 2024-2025 | |
| Highridge Medical LLC | $2,693.85 | 2024-2025 | Mobi-C Plug & Fit US, The Tether |
| Camber Spine Technologies LLC | $2,038.26 | 2020-2023 | |
| Restor3d, INC. | $533.64 | 2022 | |
| Stryker Corporation | $533.59 | 2019 | |
| Medtronic, INC. | $466.56 | 2021-2025 | Mazor X System, O-Arm, Stealthstation S8 Platform |
| Carlsmed, INC. | $237.08 | 2021-2022 | |
| Medtronic USA, INC. | $83.19 | 2019-2020 | |
| Alon Medical Technology | $51.36 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.89 | 2020-2021 | |
| Nalu Medical, INC. | $21.81 | 2024 | Nalu Neurostimulation System |
| Ibsa Pharma INC. | $21.36 | 2022 | |
| Baxter Healthcare | $21.29 | 2019 | |
| Radius Health, INC. | $16.45 | 2019 | |
| Abbvie INC. | $16.29 | 2023 | Botox |
| Virtus Pharmaceuticals LLC | $16.02 | 2023 | Levorphanol Tartrate |
| Spineology INC. | $13.04 | 2023 | Optimesh Expandable Interbody Fusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,918.13 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Najeeb Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.